Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 316

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

A Comparative Study of Hollow Copper Sulfide Nanoparticles and Hollow Gold Nanospheres on Degradability and Toxicity

Open access
Guo, Liangran, Panderi, Irene, Yan, Daisy D., Szulak, Kevin, Li, Yajuan, Chen, Yi-Tzai, Ma, Hang, Niesen, Daniel B., Seeram, Navindra, Ahmed, Aftab, Yan, Bingfang, Pantazatos, Dionysios, Lu, Wei·2013·ACS Nano
DOI 10.1021/nn403202w
Open this paper in CoChat — free account

Abstract

Gold and copper nanoparticles have been widely investigated for photothermal therapy of cancer. However, degradability and toxicity of these nanoparticles remain concerns. Here, we compare hollow CuS nanoparticles (HCuSNPs) with hollow gold nanospheres (HAuNS) in similar particle sizes and morphology following intravenous administration to mice. The injected pegylated HCuSNPs (PEG-HCuSNPs) are eliminated through both hepatobiliary (67 percentage of injected dose, %ID) and renal (23 %ID) excretion within one month postinjection. By contrast, 3.98 %ID of Au is excreted from liver and kidney within one month after iv injection of pegylated HAuNS (PEG-HAuNS). Comparatively, PEG-HAuNS are almost nonmetabolizable, while PEG-HCuSNPs are considered biodegradable nanoparticles. PEG-HCuSNPs do not show significant toxicity by histological or blood chemistry analysis. Principal component analysis and 2-D peak distribution plots of data from matrix-assisted laser desorption ionization-time-of-flight imaging mass spectrometry (MALDI-TOF IMS) of liver tissues demonstrated a reversible change in the proteomic profile in mice receiving PEG-HCuSNPs. This is attributed to slow dissociation of Cu ion from CuS nanoparticles along with effective Cu elimination for maintaining homeostasis. Nonetheless, an irreversible change in the proteomic profile is observed in the liver from mice receiving PEG-HAuNS by analysis of MALDI-TOF IMS data, probably due to the nonmetabolizability of Au. This finding correlates with the elevated serum lactate dehydrogenase at 3 months after PEG-HAuNS injection, indicating potential long-term toxicity. The comparative results between the two types of nanoparticles will advance the development of HCuSNPs as a new class of biodegradable inorganic nanomaterials for photothermal therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/nn403202w

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 45

  1. Lal S., 2008, Acc. Chem. Res., 41, 1842, 10.1021/ar800150g · DOI · Paper page
  2. Alkilany A. M., 2012, Adv. Drug Delivery Rev., 64, 190, 10.1016/j.addr.2011.03.005 · DOI · Paper page
  3. Xia Y., 2011, Acc. Chem. Res., 44, 914, 10.1021/ar200061q · DOI · Paper page
  4. Melancon M. P., 2011, Acc. Chem. Res., 44, 947, 10.1021/ar200022e · DOI · Paper page
  5. Li Y., 2010, Nanomedicine (London, U.K.), 5, 1161, 10.2217/nnm.10.85 · DOI · Paper page
  6. Zhou M., 2010, J. Am. Chem. Soc., 132, 15351, 10.1021/ja106855m · DOI · Paper page
  7. Tian Q., 2011, Adv. Mater., 23, 3542, 10.1002/adma.201101295 · DOI · Paper page
  8. Tian Q., 2011, ACS Nano, 5, 9761, 10.1021/nn203293t · DOI · Paper page
  9. Sadauskas E., 2009, Nanomedicine, 5, 162, 10.1016/j.nano.2008.11.002 · DOI · Paper page
  10. Balasubramanian S. K., 2010, Biomaterials, 31, 2034, 10.1016/j.biomaterials.2009.11.079 · DOI · Paper page
  11. Ku G., 2012, ACS Nano, 6, 7489, 10.1021/nn302782y · DOI · Paper page
  12. Uriu-Adams J. Y., 2005, Mol. Aspects Med., 26, 268, 10.1016/j.mam.2005.07.015 · DOI · Paper page
  13. Lu W., 2009, Clin. Cancer Res., 15, 876, 10.1158/1078-0432.CCR-08-1480 · DOI · Paper page
  14. Ramadan S., 2012, Small, 8, 3143, 10.1002/smll.201200783 · DOI
  15. Li S. D., 2008, Mol. Pharmaceutics, 5, 496, 10.1021/mp800049w · DOI · Paper page
  16. Welch A. J., 1984, IEEE J. Quantum Electron., 20, 1471, 10.1109/JQE.1984.1072339 · doi:10.1109/jqe.1984.1072339
  17. Diederich C. J., 2005, Int. J. Hyperthermia, 21, 745, 10.1080/02656730500271692 · DOI · Paper page
  18. Lipka J., 2010, Biomaterials, 31, 6574, 10.1016/j.biomaterials.2010.05.009 · DOI · Paper page
  19. Jokerst J. V., 2011, Nanomedicine (London, U.K.), 6, 715, 10.2217/nnm.11.19 · DOI · Paper page
  20. Zhu H., 2009, Inorg. Chem., 48, 7099, 10.1021/ic900201p · doi:10.1021/ic900201p
  21. Choi C. H., 2011, Proc. Natl. Acad. Sci. U.S.A., 108, 6656, 10.1073/pnas.1103573108 · DOI · Paper page
  22. Choi H. S., 2009, Nano Lett., 9, 2354, 10.1021/nl900872r · DOI · Paper page
  23. Lu W., 2010, Biomaterials, 31, 2617, 10.1016/j.biomaterials.2009.12.007 · DOI · Paper page
  24. Mercer J. F., 2003, J. Nutr., 133, 1481S, 10.1093/jn/133.5.1481S · DOI
  25. Melancon M. P., 2008, Mol. Cancer Ther., 7, 1730, 10.1158/1535-7163.MCT-08-0016 · DOI · Paper page
  26. Liu T., 2011, Biomaterials, 32, 1657, 10.1016/j.biomaterials.2010.10.035 · DOI · Paper page
  27. Shi D., 2010, Biochem. Pharmacol., 80, 1274, 10.1016/j.bcp.2010.06.043 · doi:10.1016/j.bcp.2010.06.043
  28. Yang D., 2012, J. Lipid Res., 53, 529, 10.1194/jlr.M014688 · doi:10.1194/jlr.m014688
  29. Shao C., 2012, Am. J. Biomed. Sci., 4, 85, 10.5099/aj120100085 · doi:10.5099/aj120100085
  30. Ketterlinus R., 2005, BioTechniques, 37, 10.2144/05386SU07 · doi:10.2144/05386su07
  31. Cho Y. T., 2013, Clin. Chim. Acta, 415, 266, 10.1016/j.cca.2012.10.032 · doi:10.1016/j.cca.2012.10.032
  32. Caldwell R. L., 2005, Mol. Cell. Proteomics, 4, 394, 10.1074/mcp.R500006-MCP200 · DOI · Paper page
  33. Cornett D. S., 2007, Nat. Methods, 4, 828, 10.1038/nmeth1094 · DOI · Paper page
  34. Alexandrov T., 2012, BMC Bioinf., 13, S11, 10.1186/1471-2105-13-S16-S11 · DOI
  35. Andersson M., 2008, Nat. Methods, 5, 101, 10.1038/nmeth1145 · DOI
  36. Wisztorski M., 2008, Dev. Neurobiol., 68, 845, 10.1002/dneu.20623 · DOI
  37. Chaurand P., 2006, Curr. Opin. Biotechnol., 17, 431, 10.1016/j.copbio.2006.06.002 · DOI
  38. Wisztorski M., 2007, Curr. Pharm. Des., 13, 3317, 10.2174/138161207782360672 · DOI
  39. Arredondo M., 2005, Mol. Aspects Med., 26, 313, 10.1016/j.mam.2005.07.010 · DOI · Paper page
  40. Furukawa T., 2008, Curr. Med. Chem., 15, 3268, 10.2174/092986708786848479 · DOI
  41. Weiner A. L., 1980, Biochim. Biophys. Acta, 629, 113, 10.1016/0304-4165(80)90270-6 · DOI
  42. Webb M., 1982, Biochem. Pharmacol., 31, 137, 10.1016/0006-2952(82)90202-7 · DOI · Paper page
  43. Bremner I., 1990, Annu. Rev. Nutr., 10, 63, 10.1146/annurev.nu.10.070190.000431 · DOI · Paper page
  44. Freedman J. H., 1989, J. Biol. Chem., 264, 5598, 10.1016/S0021-9258(18)83589-X · DOI · Paper page
  45. Cheng K., 2009, J. Am. Chem. Soc., 131, 10637, 10.1021/ja903300f · DOI · Paper page

Cited by

See all 316

Metadata

Authors
Guo, L., Panderi, I., Yan, D. D., Szulak, K., Li, Y., Chen, Y.-T., Ma, H., Niesen, D. B., Seeram, N., Ahmed, A., Yan, B., Pantazatos, D., & Lu, W.
Venue
ACS Nano
Publisher
American Chemical Society (ACS)
Published
2013-10-01
Volume
7
Issue
10
Pages
8780-8793
ISSN
  • 1936-0851 (ISSN-L)
  • 1936-086X
DOI
10.1021/nn403202w
OpenAlex
W1989834585
Cited by
316
References
3
FWCI
9.57
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.